NDTP (was MILV) is hours to days away now from the Biotech R/M SEC filings IMHO. The last step that turns the lights on.
Last chance to get in before the rocket ride.
Float lock of 290,000 shares, AS 450K shares biotech birth inbound known to be coming. I expect an SEC S-1 at the Min, or an SEC 1-A with 40 Mil $$$ cash raise and immediate uplist to the NYSE
$100 to $300/share targets have been estimated based my DD of the technology they disclosed in a 2016 SEC filing.
Details on the history of the private Biotech R/M into it: